Cite
Hospach I, Goldstein J, Harenski K, et al. In vitro characterization of PrismaLung+: a novel ECCO. Intensive Care Med Exp. 2020;8(1):14doi: 10.1186/s40635-020-00301-7.
Hospach, I., Goldstein, J., Harenski, K., Laffey, J. G., Pouchoulin, D., Raible, M., Votteler, S., & Storr, M. (2020). In vitro characterization of PrismaLung+: a novel ECCO. Intensive care medicine experimental, 8(1), 14. https://doi.org/10.1186/s40635-020-00301-7
Hospach, Ingeborg, et al. "In vitro characterization of PrismaLung+: a novel ECCO." Intensive care medicine experimental vol. 8,1 (2020): 14. doi: https://doi.org/10.1186/s40635-020-00301-7
Hospach I, Goldstein J, Harenski K, Laffey JG, Pouchoulin D, Raible M, Votteler S, Storr M. In vitro characterization of PrismaLung+: a novel ECCO. Intensive Care Med Exp. 2020 May 13;8(1):14. doi: 10.1186/s40635-020-00301-7. PMID: 32405714; PMCID: PMC7221037.
Copy
Download .nbib